COPD

We must do more to protect people from the health risks

Ensifentrine also reduced moderate-to-severe exacerbations

Reduced exacerbations, pneumonia hospitalizations seen versus ICS-LABAs in observational study

In retrospective study, 54% mortality rate for those with mucus plugs in 3 or more lung segments

Lung function and symptoms also bettered with biologic in patients with type 2 Inflammation

Lower MoCA scores associated with improper inhaler use despite face-to-face training

OTC devices don't work as well as prescription devices -- if they work at all, study shows

Race, not income, was primary sociodemographic characteristic distinguishing exposure levels

Infection might disrupt or reflect disrupted childhood lung development, researchers say

CAPTURE highlights challenges in detecting patients with undiagnosed COPD

Population-based score had low sensitivity compared with the bedside Clinical Frailty Scale

Also in TTHealthWatch: stopping cervical cancer screening

More research needed to distinguish physiological from behavioral effects of dyspnea

Early detection remains elusive, but treatments are reducing deaths